UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that inhibiting the enzyme CARM1 (also called PRMT4) dramatically slows acute myeloid leukemia (AML) progression but does not affect normal blood production.

Full Story

Related posts

MPFI Scientist Receives More than $2 Million to Study Regulation of Instructive Signaling in the Cerebellum

Dr. Jason Christie, MPFI Research Group Leader, has been awarded a grant in the amount…

FIU: Professional mediation can help Everglades restoration

Independent mediators – what the researchers call “wetland restoration brokers” – could help navigate the…

FIU: Treatment being developed for manatees poisoned by red tide

Florida International University and Mote Marine Laboratory are developing new and more efficient ways to…